Contact Your Members of Congress: Sign the Part B Drug Payment Letter Today!
CMS released a proposed rule outlining a five year, two-phase mandatory demonstration project that would modify drug reimbursement based on geographic areas. In Phase 1, Medicare seeks to adjust the ASP + 6% reimbursement to ASP + 2.5% with a flat fee of $16.80. In the second phase, Medicare would implement value-based purchasing tools, engineered by CMS, in conjunction with the Phase 1 variation of the ASP adjustment.
The proposed rule could have a serious impact on community-based cancer clinics and could further exacerbate the shift of cancer patients moving into the more expensive hospital based setting. This demonstration project could result in significant differences in the cost and quality of cancer care that Medicare patients receive based solely on their zip code.
Time is running out for Congress to weigh in on this flawed proposal. Urge your Members of Congress to sign on to the Medicare Part B Drug Payment letters today!
Click Here to Urge Your Members of Congress to Sign the Congressional Part B Drug Payment Letters
To view a one-page talking points memo, CLICK HERE.
To view the proposed rule, CLICK HERE.